Physician profile
Joseph Chiaramonte
NPI 1982609947
$5,084.21
in general payments reported to CMS, 2019-2025
34 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,420 · 2020: $1,664.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $698.63 | 2019-2020 | |
| Novo Nordisk INC | $588.58 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $576.98 | 2019-2020 | |
| Amgen INC. | $320.48 | 2019-2020 | |
| Antares Pharma, INC. | $311.05 | 2019-2020 | |
| Amarin Pharma, INC. | $297.62 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $272.21 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $202.83 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $180.06 | 2019-2020 | |
| Glaxosmithkline, LLC. | $179.28 | 2019-2020 | |
| Lilly USA, LLC | $169.39 | 2019-2020 | |
| Aytu Biopharma, INC. | $146.52 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $129.09 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $124.96 | 2019 | |
| Pfizer INC. | $99.40 | 2019-2020 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $89.50 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $84.75 | 2019-2020 | |
| Allergan, INC. | $83.30 | 2019-2020 | |
| Radius Health, INC. | $75.68 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $72.84 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $63.33 | 2019 | |
| Novartis Pharmaceuticals Corporation | $51.59 | 2019 | |
| Sanofi-Aventis U.S. LLC | $47.15 | 2019-2020 | |
| Ibsa Pharma INC. | $35.41 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $31.42 | 2019 | |
| Amag Pharmaceuticals, INC. | $22.18 | 2019 | |
| Abbott Laboratories | $20.22 | 2020 | |
| Ironshore Pharmaceuticals INC. | $17.89 | 2019 | |
| Phadia US INC. | $17.83 | 2019 | |
| Scilex Pharmaceuticals INC. | $16.61 | 2019 | |
| Amneal Pharmaceuticals LLC | $15.97 | 2019 | |
| Sanofi Pasteur INC. | $15.34 | 2019 | |
| Ascensia Diabetes Care US INC. | $13.90 | 2019 | |
| Neos Therapeutics, LP | $12.22 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Chiaramonte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.